John Couling Sells 7,667 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the company’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total transaction of $460,020.00. Following the transaction, the senior vice president owned 118,727 shares in the company, valued at approximately $7,123,620. The trade was a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Price Performance

Shares of Dolby Laboratories stock opened at $60.87 on Friday. The firm has a market cap of $5.76 billion, a PE ratio of 25.90 and a beta of 0.80. The stock has a fifty day moving average price of $52.70 and a 200-day moving average price of $58.47. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $75.66.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities analysts anticipate that Dolby Laboratories will post 3.21 EPS for the current fiscal year.

Dolby Laboratories declared that its board has approved a share buyback plan on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to reacquire up to 7% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Analysts Set New Price Targets

DLB has been the topic of several recent research reports. Barrington Research reiterated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, July 31st. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Institutional Investors Weigh In On Dolby Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp bought a new position in shares of Dolby Laboratories during the second quarter valued at about $253,289,000. State Street Corp increased its holdings in Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after purchasing an additional 180,072 shares during the period. First Trust Advisors LP raised its holdings in shares of Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after acquiring an additional 374,405 shares in the last quarter. Geode Capital Management LLC raised its holdings in Dolby Laboratories by 15.6% in the 4th quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock worth $122,749,000 after purchasing an additional 254,250 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.